FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310120141> ?p ?o ?g. }

• W4310120141 endingPage "1421" @default.
• W4310120141 startingPage "1420" @default.
• W4310120141 abstract "Background: Ascorbic acid (AA, vitamin C) deficiency is easily overlooked in the differential of patients with bruising and bleeding. While studies suggest that the incidence may be declining in the U.S in recent years, we recognized this entity clinically in the work-up of patients with unexplained bleeding or nutritional deficiencies. We analyzed AA testing and deficiency at a single institution to determine its relative incidence and associated clinical phenotype across moderate and severe deficiency. Methods: We performed a retrospective review of MCF patients from January 1, 2018 through December 31, 2019 who underwent AA testing in a CLIA-certified standard of care laboratory following IRB approval. Deficiency was defined as an AA level ≤0.3 mg/dL. Patients were evaluated with a systematic EMR review including demographic information, presence of associated symptoms (i.e., clinical bleeding or easy bruising or bleeding reported on the electronic review of systems), and markers of malnutrition/malabsorption. History of hematologic disorder (e.g. sickle cell disease, thalassemia, hematologic malignancy); hematologic complications of renal disease, liver disease, solid tumor, or scleroderma; multivitamin or proton pump inhibitor use; and associated gastrointestinal (GI) disorders (i.e. inflammatory bowel disease) and gastric bypass surgery were included. Continuous variables were summarized with the sample median and range and categorical variables with number and percentage of patients. The proportion of patients with AA deficiency was estimated along with a 95% confidence interval (CI). AA deficient patient characteristics were compared according to AA level (i.e., 0.1 mg/dL vs. 0.2 or 0.3 mg/dL) using a Kruskal-Wallis rank sum test or Fisher's exact test. P-values <0.05 were considered statistically significant. All tests were two-sided. Statistical analysis was performed using R Statistical Software. Results: We identified 1,124 patients who underwent AA testing over 24 months, and n=245 (21.8%, 95% CI: 19.5% - 24.3%) were deficient. Of those, n=23 (9.4 %) reported symptoms of mucocutaneous bleeding (predominantly ecchymosis, easy bruising or epistaxis) and n=19 (7.8%) had GI or genitourinary (GU) bleeding. There were 42 bleeding events among 39 patients (15.9%), 3 of whom had combined mucocutaneous and GU bleeding. 100 of the deficient patients (40.8%) were taking an oral multivitamin. 171 patients (69.8%) underwent prior bariatric surgery. 79 of these (46.2%) were AA deficient before surgery. Patients were analyzed according to the degree of AA deficiency (i.e., 0.1 mg/dL vs. 0.2 mg/dL or 0.3 mg/dL, respectively) to determine the clinical characteristics associated with profound deficiency; Table 1. Significant associations were observed for ethnicity (Hispanic or Latino: 1.8% vs. 2.2% vs. 10.0%, p=0.036), reported marijuana or illicit drug use (5.2% vs. 10.9% vs. 2.2%, p=0.049), and history of underlying hematologic diagnosis, specifically predisposition to iron overload (19% vs. 23.9% vs. 9.5%, p=0.039). Eating disorder/restrictive diet, alcohol, gastric bypass surgery, PPI use, degree of hematologic abnormality on CBC, and other markers of nutritional deficiency were not associated with the degree of AA deficiency. Conclusion: AA deficiency is surprisingly common but underappreciated in current practice. Nearly 22% of patients tested were deficient despite 41% of them reporting multivitamin use, and they often endorsed bleeding symptoms. We identified clinically relevant characteristics associated with the degree of AA deficiency, including drug use, hematologic disorder, and ethnicity. We found no association with risk factors like eating disorders, PPI use, and gastric bypass. While the etiology of bleeding dysfunction in this population may be multifactorial, AA deficiency likely contributes and represents a reversible cause. AA deficiency is easily confirmed and should be considered in the work-up of unexplained or easy bruising/bleeding in the absence of other clear etiologies. Figure 1View largeDownload PPTFigure 1View largeDownload PPT Close modal" @default.
• W4310120141 created "2022-11-30" @default.
• W4310120141 creator A5003416563 @default.
• W4310120141 creator A5016236600 @default.
• W4310120141 creator A5017841698 @default.
• W4310120141 creator A5031027678 @default.
• W4310120141 creator A5035051206 @default.
• W4310120141 creator A5042358094 @default.
• W4310120141 creator A5046210345 @default.
• W4310120141 creator A5064781310 @default.
• W4310120141 creator A5089383415 @default.
• W4310120141 creator A5091676720 @default.
• W4310120141 date "2022-11-15" @default.
• W4310120141 modified "2023-10-18" @default.
• W4310120141 title "Prevalence of Vitamin C Deficiency and Bleeding at a Tertiary Care Center: Mayo Clinic Florida (MCF) Experience" @default.
• W4310120141 doi "https://doi.org/10.1182/blood-2022-170199" @default.
• W4310120141 hasPublicationYear "2022" @default.
• W4310120141 type Work @default.
• W4310120141 citedByCount "0" @default.
• W4310120141 crossrefType "journal-article" @default.
• W4310120141 hasAuthorship W4310120141A5003416563 @default.
• W4310120141 hasAuthorship W4310120141A5016236600 @default.
• W4310120141 hasAuthorship W4310120141A5017841698 @default.
• W4310120141 hasAuthorship W4310120141A5031027678 @default.
• W4310120141 hasAuthorship W4310120141A5035051206 @default.
• W4310120141 hasAuthorship W4310120141A5042358094 @default.
• W4310120141 hasAuthorship W4310120141A5046210345 @default.
• W4310120141 hasAuthorship W4310120141A5064781310 @default.
• W4310120141 hasAuthorship W4310120141A5089383415 @default.
• W4310120141 hasAuthorship W4310120141A5091676720 @default.
• W4310120141 hasBestOaLocation W43101201411 @default.
• W4310120141 hasConcept C126322002 @default.
• W4310120141 hasConcept C185592680 @default.
• W4310120141 hasConcept C2779463800 @default.
• W4310120141 hasConcept C2991842025 @default.
• W4310120141 hasConcept C71924100 @default.
• W4310120141 hasConcept C74909509 @default.
• W4310120141 hasConcept C8010536 @default.
• W4310120141 hasConceptScore W4310120141C126322002 @default.
• W4310120141 hasConceptScore W4310120141C185592680 @default.
• W4310120141 hasConceptScore W4310120141C2779463800 @default.
• W4310120141 hasConceptScore W4310120141C2991842025 @default.
• W4310120141 hasConceptScore W4310120141C71924100 @default.
• W4310120141 hasConceptScore W4310120141C74909509 @default.
• W4310120141 hasConceptScore W4310120141C8010536 @default.
• W4310120141 hasIssue "Supplement 1" @default.
• W4310120141 hasLocation W43101201411 @default.
• W4310120141 hasOpenAccess W4310120141 @default.
• W4310120141 hasPrimaryLocation W43101201411 @default.
• W4310120141 hasRelatedWork W2031733627 @default.
• W4310120141 hasRelatedWork W2133648025 @default.
• W4310120141 hasRelatedWork W2273265398 @default.
• W4310120141 hasRelatedWork W2855509430 @default.
• W4310120141 hasRelatedWork W2946903244 @default.
• W4310120141 hasRelatedWork W3091813348 @default.
• W4310120141 hasRelatedWork W3137263057 @default.
• W4310120141 hasRelatedWork W3208043173 @default.
• W4310120141 hasRelatedWork W3209024356 @default.
• W4310120141 hasRelatedWork W2419347366 @default.
• W4310120141 hasVolume "140" @default.
• W4310120141 isParatext "false" @default.
• W4310120141 isRetracted "false" @default.
• W4310120141 workType "article" @default.